These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 5125182)
41. [The effect of rifampicin on a typical mycobacterial diseases]. Yamamoto M; Aoki M; Okada S; Kawabe H; Kita N Kekkaku; 1972 Nov; 47(11):399-403. PubMed ID: 4649485 [No Abstract] [Full Text] [Related]
42. A study of pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: clinical characteristics. XX. A report of the Veterans Administration-armed forces cooperative study on the chemotherapy of tuberculosis. Bates JH Am Rev Respir Dis; 1967 Dec; 96(6):1151-7. PubMed ID: 4964449 [No Abstract] [Full Text] [Related]
43. [A new Mycobacterium considered as lung pathogen (Mycobacterium acetamidolyticum sp. nov.)]. Tsukamura M; Amano H; Mizuno S Kekkaku; 1986 Apr; 61(4):257-64. PubMed ID: 3735904 [No Abstract] [Full Text] [Related]
44. Pulmonary disease caused by Mycobacterium xenopei. Doyle WM; Evander LC; Gurft H Am Rev Respir Dis; 1968 May; 97(5):919-22. PubMed ID: 5647216 [No Abstract] [Full Text] [Related]
45. [Determination of gentamicin in the sputum of patients with chronic suppurative bronchitis]. Puchelle E; Pham QT Pathol Biol (Paris); 1974 Sep; 22(7):575-9. PubMed ID: 4612461 [No Abstract] [Full Text] [Related]
46. Subcutaneous abscesses due to Mycobacterium fortuitum. Report of a case. Canilang B; Armstrong D Am Rev Respir Dis; 1968 Mar; 97(3):451-4. PubMed ID: 5638498 [No Abstract] [Full Text] [Related]
47. A cluster of Mycobacterium gordonae isolates from bronchoscopy specimens. Steere AC; Corrales J; von Graevenitz A Am Rev Respir Dis; 1979 Jul; 120(1):214-6. PubMed ID: 464382 [TBL] [Abstract][Full Text] [Related]
48. [Clinical study of cases discharging unclassified mycobacteria]. Nagano H Kekkaku; 1968 Nov; 43(11):461-72. PubMed ID: 5716321 [No Abstract] [Full Text] [Related]
49. Background factors for casual isolation of Mycobacterium intracellulare from sputum of patients with tuberculosis. Tsukamura M Am Rev Respir Dis; 1973 Sep; 108(3):679-83. PubMed ID: 4200818 [No Abstract] [Full Text] [Related]
50. A study of mycobacterial species isolated from patients with chronic respiratory disease. Shriniwas ; Bhatia VN Am Rev Respir Dis; 1973 Aug; 108(2):378-81. PubMed ID: 4198351 [No Abstract] [Full Text] [Related]
51. The Australian rifampicin trial. Proust A; Evans C Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286 [No Abstract] [Full Text] [Related]
52. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays. Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065 [TBL] [Abstract][Full Text] [Related]